These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 16395871

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Are ecstasy induced serotonergic alterations overestimated for the majority of users?
    Szigeti B, Winstock AR, Erritzoe D, Maier LJ.
    J Psychopharmacol; 2018 Jul; 32(7):741-748. PubMed ID: 29733742
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Meta-analysis of molecular imaging of serotonin transporters in ecstasy/polydrug users.
    Roberts CA, Jones A, Montgomery C.
    Neurosci Biobehav Rev; 2016 Apr; 63():158-67. PubMed ID: 26855234
    [Abstract] [Full Text] [Related]

  • 32. Ecstasy (MDMA) exposure and neuropsychological functioning: a polydrug perspective.
    Medina KL, Shear PK, Corcoran K.
    J Int Neuropsychol Soc; 2005 Oct; 11(6):753-65. PubMed ID: 16248911
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users.
    Gouzoulis-Mayfrank E, Thimm B, Rezk M, Hensen G, Daumann J.
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Aug; 27(5):819-27. PubMed ID: 12921915
    [Abstract] [Full Text] [Related]

  • 38. Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug users.
    Parrott AC, Sisk E, Turner JJ.
    Drug Alcohol Depend; 2000 Jul 01; 60(1):105-10. PubMed ID: 10821995
    [Abstract] [Full Text] [Related]

  • 39. Recreational ecstasy use and the neurotoxic potential of MDMA: current status of the controversy and methodological issues.
    Lyvers M.
    Drug Alcohol Rev; 2006 May 01; 25(3):269-76. PubMed ID: 16753651
    [Abstract] [Full Text] [Related]

  • 40. MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users.
    Parrott AC.
    Neurosci Biobehav Rev; 2013 Sep 01; 37(8):1466-84. PubMed ID: 23660456
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.